Kuros Biosciences AG
SIX:KURN.SW
16.78 (CHF) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CHF.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 33.564 | 17.986 | 13.815 | 4.039 | 2.561 | 0.715 | 0.534 | 1.061 | 6.355 | 1 | 1 | 1.1 | 1.571 | 22.349 | 9.108 | 19.723 | 35.882 | 0.724 | 4.358 | 4.112 |
| Cost of Revenue
| 5.78 | 7.217 | 3.749 | 2.368 | 2.64 | 3.416 | 3.305 | 7.909 | 0.563 | 10.101 | 12.949 | 0 | 0 | 0 | 0 | 0 | 17.399 | 11.2 | 0 | 0 |
| Gross Profit
| 27.784 | 10.769 | 10.066 | 1.671 | -0.079 | -2.701 | -2.771 | -6.848 | 5.792 | -9.101 | -11.949 | 1.1 | 1.571 | 22.349 | 9.108 | 19.723 | 18.483 | -10.476 | 4.358 | 4.112 |
| Gross Profit Ratio
| 0.828 | 0.599 | 0.729 | 0.414 | -0.031 | -3.778 | -5.189 | -6.454 | 0.911 | -9.101 | -11.949 | 1 | 1 | 1 | 1 | 1 | 0.515 | -14.47 | 1 | 1 |
| Reseach & Development Expenses
| 5.599 | 5.194 | 4.989 | 4.005 | 6.477 | 6.882 | 4.47 | 7.909 | 1.085 | 17.473 | 20.449 | 10.888 | 16.692 | 22.214 | 32.972 | 39.495 | 0 | 0 | 29.478 | 26.137 |
| General & Administrative Expenses
| 3.557 | 3.069 | 2.582 | 3.136 | 1.543 | 2.772 | 1.822 | 17.07 | 7.323 | 5.276 | 5.402 | 4.977 | 5.476 | 4.085 | 2.998 | 3.67 | 1.405 | 1.455 | 3.778 | 3.616 |
| Selling & Marketing Expenses
| 17.134 | 8.084 | 4.799 | 1.559 | 2.304 | 0.348 | 0 | 0 | 0.046 | 0.202 | 0.473 | 0.33 | 0.471 | 0.738 | 0.858 | 0.958 | 0 | 0 | 0 | 0 |
| SG&A
| 31.09 | 11.153 | 7.381 | 4.695 | 1.543 | 2.772 | 1.822 | 17.07 | 7.369 | 5.478 | 5.875 | 5.307 | 5.947 | 4.823 | 3.856 | 4.628 | 1.405 | 1.455 | 3.778 | 3.616 |
| Other Expenses
| 0 | 7.868 | 6.463 | 4.65 | 9.77 | 8.254 | 9.453 | -2.599 | -2.753 | -3.014 | -2.058 | -1.6 | -1.354 | -0.824 | -0.481 | -0.512 | -0.012 | 0.002 | 0.419 | -1.465 |
| Operating Expenses
| 36.689 | 24.215 | 18.833 | 13.35 | 11.313 | 11.026 | 11.275 | 22.407 | 5.138 | 9.836 | 24.266 | 14.595 | 21.285 | 26.213 | 36.347 | 43.611 | 27.807 | 25.04 | 33.675 | 28.288 |
| Operating Income
| -8.905 | -13.446 | -8.767 | -11.679 | -11.392 | -13.727 | -16.243 | -21.346 | 0.654 | -18.937 | -23.266 | -13.495 | -19.714 | -3.864 | -27.239 | -23.883 | -8.3 | -35.091 | -29.317 | -24.176 |
| Operating Income Ratio
| -0.265 | -0.748 | -0.635 | -2.892 | -4.448 | -19.199 | -30.418 | -20.119 | 0.103 | -18.937 | -23.266 | -12.268 | -12.549 | -0.173 | -2.991 | -1.211 | -0.231 | -48.468 | -6.727 | -5.879 |
| Total Other Income Expenses Net
| -4.442 | -2.545 | -0.787 | -0.415 | -0.431 | -0.086 | -2.547 | 1.042 | 5.573 | -15.089 | -7.56 | 3.347 | 0.935 | 2.41 | 2.413 | -2.121 | -0.542 | 0.964 | 0 | 0 |
| Income Before Tax
| -13.347 | -15.991 | -9.554 | -12.094 | -11.823 | -13.813 | -16.593 | -20.277 | 6.227 | -34.026 | -30.826 | -10.148 | -18.779 | -1.454 | -24.826 | -26.009 | -9.866 | -34.552 | 0 | 0 |
| Income Before Tax Ratio
| -0.398 | -0.889 | -0.692 | -2.994 | -4.617 | -19.319 | -31.073 | -19.111 | 0.98 | -34.026 | -30.826 | -9.225 | -11.954 | -0.065 | -2.726 | -1.319 | -0.275 | -47.724 | 0 | 0 |
| Income Tax Expense
| 0.38 | -1.396 | -2.013 | -0.574 | -0.571 | -2.12 | -0.109 | -0.533 | -0.046 | 0.2 | 0.265 | -0.932 | 3.928 | 6.58 | 6.929 | 2.39 | -2.991 | 0.539 | -0.837 | -0.326 |
| Net Income
| -13.727 | -14.595 | -7.541 | -11.52 | -11.252 | -11.693 | -16.484 | -19.744 | 6.227 | -34.026 | -30.826 | -9.216 | -18.779 | -1.454 | -24.826 | -26.009 | -6.875 | -34.552 | -28.48 | -23.85 |
| Net Income Ratio
| -0.409 | -0.811 | -0.546 | -2.852 | -4.394 | -16.354 | -30.869 | -18.609 | 0.98 | -34.026 | -30.826 | -8.378 | -11.954 | -0.065 | -2.726 | -1.319 | -0.192 | -47.724 | -6.535 | -5.8 |
| EPS
| -0.38 | -0.43 | -0.23 | -0.47 | -0.66 | -1.14 | -1.88 | -3.19 | -226.97 | -96.7 | -106.63 | -45.88 | -287.82 | -22.29 | -380.59 | -399.02 | -106.15 | -542.49 | -461.63 | -435.51 |
| EPS Diluted
| -0.38 | -0.43 | -0.23 | -0.47 | -0.66 | -1.14 | -1.88 | -3.19 | -226.97 | -96.7 | -106.63 | -45.88 | -287.82 | -22.29 | -380.59 | -399.02 | -106.15 | -542.49 | -461.63 | -435.51 |
| EBITDA
| -6.153 | -8.84 | -5.291 | -8.577 | -8.458 | -11.74 | -12.856 | -19.312 | 11.884 | -18.728 | -22.916 | -6.254 | -14.058 | 4.767 | -17.835 | -18.76 | -8.038 | -32.183 | -26.75 | -21.755 |
| EBITDA Ratio
| -0.183 | -0.491 | -0.383 | -2.124 | -3.303 | -16.42 | -24.075 | -18.202 | 1.87 | -18.728 | -22.916 | -5.685 | -8.948 | 0.213 | -1.958 | -0.951 | -0.224 | -44.452 | -6.138 | -5.291 |